Latest issue of UTRF Newsletter spotlights Jonathan Wall and team

The latest issue of the University of Tennessee (UT) Research Foundation’s monthly newsletter spotlights the work of Jonathan Wall and the team he leads at the UT Graduate School of Medicine (GSM).

As noted in this recent article, Wall, Professor and Director of Research at the GSM, has spent about 25 years studying amyloidosis. San Francisco-based Attralus, a UT licensee of the technology that Wall and the team developed, recently secured $25 million in investment financing to work on transformative medicines to improve the lives of patients with systemic amyloidosis.

You can learn more about the work of the team in this “Inventor Spotlight” article.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.